| Carl S Schreiner, MD | |
|
2423 Nw Troost St, Roseburg, OR 97471-1706 | |
| (541) 677-3400 | |
| (541) 677-3405 |
| Full Name | Carl S Schreiner |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 2423 Nw Troost St, Roseburg, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710969175 | NPI | - | NPPES |
| 139496 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD21871 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carl S Schreiner, MD 2423 Nw Troost St, Roseburg, OR 97471-1706 Ph: (541) 677-3400 | Carl S Schreiner, MD 2423 Nw Troost St, Roseburg, OR 97471-1706 Ph: (541) 677-3400 |
News Archive
Nearly 100,000 pop culture fans flocked to Emerald City Comic Con in Seattle last year, including many dressed as superheroes, aliens and robots. But something scarier than a comic book villain is roiling the conference this year — the spread of the coronavirus.
Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration for the VENTANA Companion Algorithm Progesterone Receptor (PR) (1E2) image analysis application used with the VENTANA iScan Coreo Au scanner running VIRTUOSO software.
Affymetrix, Inc. today announced at the ICHG/ASHG annual conference in Montreal, the worldwide launch of the Axiom Genome-Wide Pan-African Array, the first commercial product to maximize genomic coverage of both common and rare alleles in populations of African ancestry, including West African, East African, and African American.
A National Institutes of Health-sponsored study published in the Journal of the American Medical Association showed that lorazepam - a widely used but not yet Food and Drug Administration approved drug for children - is no more effective than an approved benzodiazepine, diazepam, for treating pediatric status epilepticus.
MRSA is the first test to be developed from Acolyte's BacLite® testing platform. BacLite reduces the time for identifying both the type of bacteria and, more importantly, the antibiotic sensitivity of the bacteria from the current 3-4 day standard to just 2-5 hours. This time advantage will mean clinicians will be able to treat, much more effectively, serious bacterial infections and prevent potentially fatal complications, such as sepsis and septic shock, from developing.
› Verified 1 days ago
James M Yun, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2423 Nw Troost St, Roseburg, OR 97471 Phone: 541-677-3400 Fax: 541-677-3405 | |
Tyson Jarad Dahl, PA-C Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2423 Nw Troost St, Roseburg, OR 97471 Phone: 541-677-3400 Fax: 541-677-3405 | |
Dr. James Dennis Scott, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 300 Independence Ln, Roseburg, OR 97471 Phone: 541-673-3259 | |
David E. Owens, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 201, Roseburg, OR 97471 Phone: 541-440-6390 Fax: 541-440-6392 |